Cargando…

Recent Advances in Prostate Cancer Treatment and Drug Discovery

Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent years. The latest approvals include abiraterone acetate, enzalutamide and apalutamide which target androgen receptor (AR) signaling, radium-223 dichloride for reduction of bone metastases, sipuleucel-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nevedomskaya, Ekaterina, Baumgart, Simon J., Haendler, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983695/ https://www.ncbi.nlm.nih.gov/pubmed/29734647 http://dx.doi.org/10.3390/ijms19051359

Ejemplares similares

Dysregulated Transcriptional Control in Prostate Cancer
por: Baumgart, Simon J., et al.
Publicado: (2019)

From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2022)

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
por: Sugawara, Tatsuo, et al.
Publicado: (2019)

Exploiting Epigenetic Alterations in Prostate Cancer
por: Baumgart, Simon J., et al.
Publicado: (2017)

Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation
por: Baumgart, Simon J., et al.
Publicado: (2020)

Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2022)

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
por: Masci, Domiziana, et al.
Publicado: (2023)

Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Targeting DNA Damage Response in Prostate and Breast Cancer
por: Wengner, Antje M., et al.
Publicado: (2020)

Recent advances in combinatorial biosynthesis for drug discovery
por: Sun, Huihua, et al.
Publicado: (2015)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Recent Strategic Advances in CFTR Drug Discovery: An Overview
por: Rusnati, Marco, et al.
Publicado: (2020)

Recent Advances in the Discovery of Haem-Targeting Drugs for Malaria and Schistosomiasis
por: de Villiers, Katherine A., et al.
Publicado: (2009)

Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics
por: Alam, Md. Jahangir, et al.
Publicado: (2022)

Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery
por: Mehta, Pakhuri, et al.
Publicado: (2021)

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
por: Raith, Fabio, et al.
Publicado: (2023)

Recent Advances in Proteomics and Cancer Biomarker Discovery
por: Xiao, Gary Guishan, et al.
Publicado: (2008)

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
por: Lai, Yurong, et al.
Publicado: (2022)

Recent Advances in Drug Discovery from South African Marine Invertebrates
por: Davies-Coleman, Michael T., et al.
Publicado: (2015)

Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs
por: Chen, Guilin, et al.
Publicado: (2020)

Recent Advances in Aptamer Discovery and Applications
por: Zhang, Yang, et al.
Publicado: (2019)

Recent advances in Entamoeba biology: RNA interference, drug discovery, and gut microbiome
por: Morgado, Pedro, et al.
Publicado: (2016)

Recent Advances (2015–2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD
por: Dorababu, Atukuri, et al.
Publicado: (2023)

Marine Natural Products with Activities against Prostate Cancer: Recent Discoveries
por: Montuori, Eleonora, et al.
Publicado: (2023)

Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis
por: Hagaman, Daniel E., et al.
Publicado: (2021)

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
por: Xie, Xin, et al.
Publicado: (2023)

Lung Cancer Proteomics: Recent Advances in Biomarker Discovery
por: Indovina, Paola, et al.
Publicado: (2011)

Recent trends in the management of advanced prostate cancer
por: Ritch, Chad, et al.
Publicado: (2018)

Advances in Cytoprotective Drug Discovery
por: Yurchenko, Ekaterina A., et al.
Publicado: (2023)

RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches
por: Das, Agneesh Pratim, et al.
Publicado: (2023)

Recent Advances in Application of Computer-Aided Drug Design in Anti-Influenza A Virus Drug Discovery
por: Yu, Dahai, et al.
Publicado: (2022)

m6A modification: recent advances, anticancer targeted drug discovery and beyond
por: Deng, Li-Juan, et al.
Publicado: (2022)

Recent Advances in the Discovery of Novel Antiprotozoal Agents
por: Lee, Seong-Min, et al.
Publicado: (2019)

The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials
por: Xia, Mingyue, et al.
Publicado: (2021)

Recent Advances in Drug Design and Drug Discovery for Androgen-Dependent Diseases
por: Cabeza, Marisa, et al.
Publicado: (2016)

Recent advances in focal therapy of prostate and kidney cancer
por: Tsivian, Matvey, et al.
Publicado: (2010)

Advanced Cell Culture Techniques for Cancer Drug Discovery
por: Lovitt, Carrie J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c4c448tcvafq2ntvjjjj1lv5gc